There are various melanoma treatments available for patients, from conventional approaches (surgical, curette and electrodesiccation procedure, and chemotherapy) to targeted therapies (BRAF and MEK inhibitors) and immunotherapies (adoptive cell transfer, immune checkpoint inhibitors, and oncolytic virotherapy) [8,32]. Here, MAP2K7 is linked to melanoma.